HBOT HIGHLY EFFECTIVE TREATMENT FOLLOWING RADIATION THERAPY￼
HBOT HIGHLY EFFECTIVE TREATMENT FOLLOWING RADIATION THERAPY
Radiation therapy is a standard of care for many patients undergoing cancer treatments; however, when pelvic radiation is performed, it’s successes also can come with a debilitating side-effect where the bladder becomes inflamed leading to a painful and bleeding condition called hemorrhagic cystitis (HS).
This is a very difficult condition to treat. Promising new research, just published in March 2011, is now giving hope for these sufferers. This study clearly demonstrates successful therapy with long-term follow up when patients were treated with hyperbaric oxygenation therapy.
Here, a standard program of just 40 hyperbaric sessions were given to 25 patients who were diagnosed with HS. More importantly, all patients had already failed conventional therapy. So get ready for the results–ALL 25 PATIENTS IMPROVED AND WERE SUCCESSFULLY TREATED.
Furthermore, after close to 2 year follow up, no regressions were shown. The results of this study are truly remarkable and makes for a strong argument to add hyperabric oxygenation therapy to standard of care and a primary treatment option for those with HS.
The authors of the study support this previous statement by adding in the fact that hyperbaric oxygen is highly effective and safe, non-invasive therapy for HC secondary to pelvic radiation <view study>
[Management of hemorrhagic radiation cystitis with hyperbaric oxygen therapy] – PubMed (nih.gov)
29 YEAR OLD FEMALE WITH STAGE 4 BREAST CANCER RESPONDS SUCCESSFULLY TO COMBINATION THERAPY INVOLVING HYPERBARIC OXYGEN THERAPY￼
29 YEAR OLD FEMALE WITH STAGE 4 BREAST CANCER RESPONDS SUCCESSFULLY TO COMBINATION THERAPY
Triple-negative breast cancer (TNBC) is considered to be one of the more aggressive types of breast cancer, and is typically treated with chemotherapy.
Cancers like these that are able to rapidly grow and spread are a major concern and need to be treated with an equally aggressive solution. This is why we are seeing more research and clinical trials utilizing combination therapies in order to help intensify the cytotoxic effects of chemotherapy in an aggressive measure to counteract these highly metastatic cancers.
This report followed a 29 year old female that was put on an aggressive combination of chemotherapy, hyperthermia therapy, hyperbaric oxygen therapy, and a ketogenic diet. The results were remarkable and “presents evidence of a complete clinical, radiological, and pathological response following a six-month treatment period using this novel combination therapy in a patient with stage IV TNBC” <view study>
Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer – PubMed (nih.gov)